NCT03873077

Brief Summary

An anterior cruciate ligament (ACL) rupture is one of the most common sport injuries, which typically develops after a sudden knee torsion. Arthroscopic repair of the ACL is often required as a complete ACL tear can cause instability of the knee joint. During arthroscopic reconstruction the lower leg is reattached to the upper leg using part of the hamstring tendon (mm. gracilis and mm. semitendinosus). Optimal postoperative analgesia is necessary to allow a quick recovery. Intravenous analgesia during surgery is often associated with a number of side effects such as nausea, vomiting and muscle weakness and does not anesthetize the donor site of the hamstring tendon graft. Local infiltration of ropivacaine and lidocaine in the knee joint and at the donor site can be a valuable asset to control the postoperative pain. This study evaluates the effect of local infiltration analgesia (LIA) on the postoperative pain in the first month after an ACL reconstruction. Half of participants will only receive intravenous analgesia during surgery, the other half will receive intravenous analgesia and a LIA.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

March 11, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

March 13, 2019

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2020

Completed
Last Updated

March 13, 2019

Status Verified

March 1, 2019

Enrollment Period

11 months

First QC Date

March 11, 2019

Last Update Submit

March 11, 2019

Conditions

Keywords

local infiltration analgesiapostoperative analgesia

Outcome Measures

Primary Outcomes (1)

  • Visual Analogue Scale for pain

    Pain intensity using the VAS (where 0 = no pain and 100 = pain as bad as can be) 15 minutes after awakening and on Day 1, 2, 3, 7, 14, 21 and 28 after surgery.

    From moment of surgery until one month after surgery

Secondary Outcomes (4)

  • Postoperative analgesia consumption

    From moment of surgery until one month after surgery

  • General patient comfort

    From moment of surgery until one day after surgery

  • Incidence of nausea and vomiting

    From moment of surgery until hospital discharge (one day after surgery)

  • PONV treatment

    From moment of surgery until hospital discharge (one day after surgery)

Study Arms (2)

intravenous analgesia

NO INTERVENTION

Patient receives intravenous analgesia: paracetamol 30 mg/kg, diclofenac 75 mg, clonidine 1 µg/kg and morfine 0,05 mg/kg

intravenous analgesia + LIA

OTHER

Patient receives intravenous analgesia and a local infiltration analgesia in the knee

Procedure: local infiltration analgesia

Interventions

10 mL ropivacaine 7.5 mg/mL and 10 mL lidocaine 10 mg/mL

intravenous analgesia + LIA

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • elective arthroscopic anterior cruciate ligament reconstruction
  • adult

You may not qualify if:

  • unwilling or unable to grant written informed consent
  • revisions
  • contra-indication for ropivacaine

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

General Hospital Maria Middelares

Ghent, Oost-Vlaanderen, 9000, Belgium

RECRUITING

Related Publications (4)

  • Stark PA, Myles PS, Burke JA. Development and psychometric evaluation of a postoperative quality of recovery score: the QoR-15. Anesthesiology. 2013 Jun;118(6):1332-40. doi: 10.1097/ALN.0b013e318289b84b.

    PMID: 23411725BACKGROUND
  • Lefevre N, Klouche S, de Pamphilis O, Herman S, Gerometta A, Bohu Y. Peri-articular local infiltration analgesia versus femoral nerve block for postoperative pain control following anterior cruciate ligament reconstruction: Prospective, comparative, non-inferiority study. Orthop Traumatol Surg Res. 2016 Nov;102(7):873-877. doi: 10.1016/j.otsr.2016.07.011. Epub 2016 Oct 4.

    PMID: 27720193BACKGROUND
  • Kerr DR, Kohan L. Local infiltration analgesia: a technique for the control of acute postoperative pain following knee and hip surgery: a case study of 325 patients. Acta Orthop. 2008 Apr;79(2):174-83. doi: 10.1080/17453670710014950.

    PMID: 18484242BACKGROUND
  • Kristensen PK, Pfeiffer-Jensen M, Storm JO, Thillemann TM. Local infiltration analgesia is comparable to femoral nerve block after anterior cruciate ligament reconstruction with hamstring tendon graft: a randomised controlled trial. Knee Surg Sports Traumatol Arthrosc. 2014 Feb;22(2):317-23. doi: 10.1007/s00167-013-2399-x. Epub 2013 Jan 23.

    PMID: 23338666BACKGROUND

MeSH Terms

Conditions

Anterior Cruciate Ligament InjuriesPain, Postoperative

Condition Hierarchy (Ancestors)

Knee InjuriesLeg InjuriesWounds and InjuriesPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Alain F Kalmar

    Maria Middelares Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Alain F Kalmar, MD, PhD, MSc

CONTACT

Pieter Byn, MD, Msc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Group A receives standard treatment (intravenous analgesia). Group B received intravenous analgesia and a LIA.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Staff Anesthesist

Study Record Dates

First Submitted

March 11, 2019

First Posted

March 13, 2019

Study Start

March 1, 2019

Primary Completion

February 1, 2020

Study Completion

March 1, 2020

Last Updated

March 13, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

Locations